We will permit direct access to source data and documents for the purposes of trialrelated monitoring, audits, IRB/IEC review and regulatory inspections. As required by the NIH/CDC funding agency, the anonymised individual participant data will be made publicly available after publication of our results in peer-reviewed journals and no later than 24 months after the conclusion of our study.